logging in or signing up stem cell research drcmvk Download Post to : URL : Related Presentations : Share Add to Flag Embed Email Send to Blogs and Networks Add to Channel Uploaded from authorPOINT lite Insert YouTube videos in PowerPont slides with aS Desktop Copy embed code: Embed: Flash iPad Copy Does not support media & animations WordPress Embed Customize Embed URL: Copy Thumbnail: Copy The presentation is successfully added In Your Favorites. Views: 3159 Category: Science & Tech.. License: All Rights Reserved Like it (4) Dislike it (0) Added: December 28, 2009 This Presentation is Public Favorites: 0 Presentation Description No description available. Comments Posting comment... By: rameshrathodvet (20 month(s) ago) hello sir. i am Dr. Ramesh Rathod doing Ph.D at veterinary coolege bangalore. would u please help me to download stem cell ppt on my gmail rameshrathodvet@gmail.com as my research is use of autogenous stem cells in fenur fracture healing. thanking u. Saving..... Post Reply Close Saving..... Edit Comment Close By: Gangenahalli (37 month(s) ago) I request Dr.V Kumar from Bellary to allow slides on Stem Cell Research to down. If you allow me to that I thank him for that. Dr.Gangenahalli Gurudutta. Saving..... Post Reply Close By: vkumar (37 month(s) ago) pl send you email id to me with professional details i will send you the copy thank you, u can also see my presentation on parenteral iron therapy fresh thinking veerendrakumarcm@gmail.com Saving..... Edit Comment Close By: vkumar (40 month(s) ago) thank you Saving..... Post Reply Close Saving..... Edit Comment Close Premium member Presentation Transcript Stem cell research : 12/28/2009 Stem cell research Dr.Veerendra Kumar C.M. MD.,DNB. Associate Professor VIMS,Bellary Slide 2: 12/28/2009 VIMS Human suffering… : 12/28/2009 Human suffering… Slide 4: 12/28/2009 Totipotent Pluripotent Multipotent Oligopotent What are stem cells? : 12/28/2009 What are stem cells? Self renewal in undifferentiated state Potencyto develop into different cells Regenerative medicine : 12/28/2009 Regenerative medicine Study of early human development Therapeutic tool for various diseases Develop and test new therapies hESC (human embryonic stem cells) : 12/28/2009 hESC (human embryonic stem cells) To study drug toxicity- liver cells & cardiomyocytes derived from SC- useful to study drug toxicityDavila ,Toxico Sci 2004;79:214-23 Types of stem cells : 12/28/2009 Types of stem cells Adult Embryonic Adult - Bone marrow, Cord blood Embryonic - Unused IVF embryos Pregnancy terminations Slide 9: 12/28/2009 Embryonic V/S adult stem cells Embryonic stem cells (ESC) : 12/28/2009 Embryonic stem cells (ESC) Embryonic cells are pluripotent and virtually immortal. Fetuses from pregnancy terminations : 12/28/2009 Fetuses from pregnancy terminations Their ability to renew themselves is limited. Animal studies have shown that it is more difficult to produce normal tissues from these cells. Adult stem cells : 12/28/2009 Adult stem cells A person’s own stem cells should be the best source of cells for transplantation. Adult stem cells will eventually substitute for embryonic stem cells. Umbilical cord stem cells : 12/28/2009 Umbilical cord stem cells Adult Stem Cells and Postnatal Stem Cells : 12/28/2009 Adult Stem Cells and Postnatal Stem Cells Advantages No ethical controversy. None to minimal risk of immune rejection. Reduced cost and time. Genetic stability. Potential disadvantage ?Limited plasticity ?Limited lifespan in culture, may carry defective gene FDA TRIALS USING ADULT OR CORD BLOOD STEM CELLS : 12/28/2009 FDA TRIALS USING ADULT OR CORD BLOOD STEM CELLS >70 current human clinical applications using adult stem cells there are no current human clinical trials involving human embryonic stem cells “It is nearly certain that the [human] clinical benefits of the [embryonic stem cell] research are years or decades away. This is a message that desperate families and patients will not want to hear.” — Science, June 17, 2005 Slide 16: 12/28/2009 Debate over hESC : 12/28/2009 Debate over hESC Objections and concerns.. : 12/28/2009 Objections and concerns.. An embryo should be accorded full human status from the moment of its creation A first step on a ‘slippery slope’ towards human reproductive cloning. Conservative vs. Liberal : 12/28/2009 Conservative vs. Liberal Conservative = Literal Translation of the Bible Liberal = Compromising Translation of Bible Question to consider: : 12/28/2009 Question to consider: Is it ethical to delay research using embryonic stem cells until adult stem cells are fully capable of treating any disease? Stem Cell Cultivation : 12/28/2009 Stem Cell Cultivation University of Wisconsin-Madison Somatic Cell Nuclear Transfer (SCNT) technique used in ‘CLONING’May be ethically acceptable as you are not using embryos by conventional methods : 12/28/2009 Somatic Cell Nuclear Transfer (SCNT) technique used in ‘CLONING’May be ethically acceptable as you are not using embryos by conventional methods Novel methods : 12/28/2009 Novel methods Extraction of single blastomere without damaging embryo and developed into independent hESC lines Chung et al ,Nature 2006; 439:216-19 Altered Nuclear Technique (ANT)genetically modifying the somatic nucleus so that induced pluripotent stem cells are producedmeissener & Jaenisch Nature 2006;439:212-15 First clinical trial using hESC : 12/28/2009 First clinical trial using hESC GERON Co, 2005-2006 Aldhous, Nature 2005;434:94-6 Existing lines of hESC : 12/28/2009 Existing lines of hESC 414 lines are available in 20 countries Characterization of these lines is limited- only 49% of lines are published in peer reviewed journals Guhr et al Stem cells 2006;24:2187-91 Derivation of hESC : 12/28/2009 Derivation of hESC Frozen embryos from IVF cycleExpanded blastocyst – ICMimmunosurgical isolation Quality poor-2nd quality embryos-cryoppreservation damages Simon et al Fertil Steril 2005;83:246-9 Maintenance of hESC : 12/28/2009 Maintenance of hESC Immortal cells in undifferentiated state Optimal growth conditions for future therapeutic applications Majority of hESC have been isolated and maintained in fetal calf serum and mouse embryonic fibroblasts as feeder cell layers (Xenoproteins and xenosupports) Problems : 12/28/2009 Problems Transmission of interspecies virus transfer Incorporation of foreign sugar molecule to hESC leading to immune response It may also lead to impairment of cell function & tissue development Varki Am J Phys Anthropol Suppl 2001 Research focus is on…. : 12/28/2009 Research focus is on…. Use of human components instead of animal sources to avoid zoonosis Fetal, adult muscle tissue, skin, Fallopian tube, endometrium, foreskin cells Successful undifferentiated growth of hESC using xenobiotic –free feeder system Richards ,Stem cells 2003;21:546-56 Research focus is on… : 12/28/2009 Research focus is on… Feeder free culture system from recombinant sources Ludwig Nature Biotech 2006;24:185-7 Differentiation : 12/28/2009 Differentiation Direct hESC to differentiate into specific cell lines - drug development- cell replacement therapeutics Specific germ cell layers can be directed by adding specific growth factors Scientific Stem Cell Challenges : 12/28/2009 Scientific Stem Cell Challenges Stem cells represents a very small fraction of cells in tissue. Isolate a small number of stem cells (finding a needle in a haystack). Expand the number of stem cells for research and clinical applications. Maintain genetic stability in culture and in recipient. Culture media has to be free of animal protein. Deliver cells to tissue of interest. Stem cells have to be functional. Avoid or restrict tissue rejection. Challenges to Stem Cell/Cloning Research : 12/28/2009 Challenges to Stem Cell/Cloning Research differentiation to the appropriate cell type(s) before using clinically. Recently, chromosome abnormalities in three human ESC lines. Challenges to Stem Cell/Cloning Research : 12/28/2009 Challenges to Stem Cell/Cloning Research Stem cell development or proliferation must be controlled once placed into patients. Possibility of rejection of stem cell transplants as foreign tissues is very high. Beware : 12/28/2009 Beware Private companies promising wonders with stem cells - mostly in countries with unregulated lawsIlic D, Regenerative med 2006;1:1-4 UKRAINE –capital of ESC ? but the references they quote do not have international authenticity in peer reviewed journals Slide 36: 12/28/2009 Slide 37: 12/28/2009 You do not have the permission to view this presentation. In order to view it, please contact the author of the presentation.
stem cell research drcmvk Download Post to : URL : Related Presentations : Share Add to Flag Embed Email Send to Blogs and Networks Add to Channel Uploaded from authorPOINT lite Insert YouTube videos in PowerPont slides with aS Desktop Copy embed code: Embed: Flash iPad Copy Does not support media & animations WordPress Embed Customize Embed URL: Copy Thumbnail: Copy The presentation is successfully added In Your Favorites. Views: 3159 Category: Science & Tech.. License: All Rights Reserved Like it (4) Dislike it (0) Added: December 28, 2009 This Presentation is Public Favorites: 0 Presentation Description No description available. Comments Posting comment... By: rameshrathodvet (20 month(s) ago) hello sir. i am Dr. Ramesh Rathod doing Ph.D at veterinary coolege bangalore. would u please help me to download stem cell ppt on my gmail rameshrathodvet@gmail.com as my research is use of autogenous stem cells in fenur fracture healing. thanking u. Saving..... Post Reply Close Saving..... Edit Comment Close By: Gangenahalli (37 month(s) ago) I request Dr.V Kumar from Bellary to allow slides on Stem Cell Research to down. If you allow me to that I thank him for that. Dr.Gangenahalli Gurudutta. Saving..... Post Reply Close By: vkumar (37 month(s) ago) pl send you email id to me with professional details i will send you the copy thank you, u can also see my presentation on parenteral iron therapy fresh thinking veerendrakumarcm@gmail.com Saving..... Edit Comment Close By: vkumar (40 month(s) ago) thank you Saving..... Post Reply Close Saving..... Edit Comment Close Premium member Presentation Transcript Stem cell research : 12/28/2009 Stem cell research Dr.Veerendra Kumar C.M. MD.,DNB. Associate Professor VIMS,Bellary Slide 2: 12/28/2009 VIMS Human suffering… : 12/28/2009 Human suffering… Slide 4: 12/28/2009 Totipotent Pluripotent Multipotent Oligopotent What are stem cells? : 12/28/2009 What are stem cells? Self renewal in undifferentiated state Potencyto develop into different cells Regenerative medicine : 12/28/2009 Regenerative medicine Study of early human development Therapeutic tool for various diseases Develop and test new therapies hESC (human embryonic stem cells) : 12/28/2009 hESC (human embryonic stem cells) To study drug toxicity- liver cells & cardiomyocytes derived from SC- useful to study drug toxicityDavila ,Toxico Sci 2004;79:214-23 Types of stem cells : 12/28/2009 Types of stem cells Adult Embryonic Adult - Bone marrow, Cord blood Embryonic - Unused IVF embryos Pregnancy terminations Slide 9: 12/28/2009 Embryonic V/S adult stem cells Embryonic stem cells (ESC) : 12/28/2009 Embryonic stem cells (ESC) Embryonic cells are pluripotent and virtually immortal. Fetuses from pregnancy terminations : 12/28/2009 Fetuses from pregnancy terminations Their ability to renew themselves is limited. Animal studies have shown that it is more difficult to produce normal tissues from these cells. Adult stem cells : 12/28/2009 Adult stem cells A person’s own stem cells should be the best source of cells for transplantation. Adult stem cells will eventually substitute for embryonic stem cells. Umbilical cord stem cells : 12/28/2009 Umbilical cord stem cells Adult Stem Cells and Postnatal Stem Cells : 12/28/2009 Adult Stem Cells and Postnatal Stem Cells Advantages No ethical controversy. None to minimal risk of immune rejection. Reduced cost and time. Genetic stability. Potential disadvantage ?Limited plasticity ?Limited lifespan in culture, may carry defective gene FDA TRIALS USING ADULT OR CORD BLOOD STEM CELLS : 12/28/2009 FDA TRIALS USING ADULT OR CORD BLOOD STEM CELLS >70 current human clinical applications using adult stem cells there are no current human clinical trials involving human embryonic stem cells “It is nearly certain that the [human] clinical benefits of the [embryonic stem cell] research are years or decades away. This is a message that desperate families and patients will not want to hear.” — Science, June 17, 2005 Slide 16: 12/28/2009 Debate over hESC : 12/28/2009 Debate over hESC Objections and concerns.. : 12/28/2009 Objections and concerns.. An embryo should be accorded full human status from the moment of its creation A first step on a ‘slippery slope’ towards human reproductive cloning. Conservative vs. Liberal : 12/28/2009 Conservative vs. Liberal Conservative = Literal Translation of the Bible Liberal = Compromising Translation of Bible Question to consider: : 12/28/2009 Question to consider: Is it ethical to delay research using embryonic stem cells until adult stem cells are fully capable of treating any disease? Stem Cell Cultivation : 12/28/2009 Stem Cell Cultivation University of Wisconsin-Madison Somatic Cell Nuclear Transfer (SCNT) technique used in ‘CLONING’May be ethically acceptable as you are not using embryos by conventional methods : 12/28/2009 Somatic Cell Nuclear Transfer (SCNT) technique used in ‘CLONING’May be ethically acceptable as you are not using embryos by conventional methods Novel methods : 12/28/2009 Novel methods Extraction of single blastomere without damaging embryo and developed into independent hESC lines Chung et al ,Nature 2006; 439:216-19 Altered Nuclear Technique (ANT)genetically modifying the somatic nucleus so that induced pluripotent stem cells are producedmeissener & Jaenisch Nature 2006;439:212-15 First clinical trial using hESC : 12/28/2009 First clinical trial using hESC GERON Co, 2005-2006 Aldhous, Nature 2005;434:94-6 Existing lines of hESC : 12/28/2009 Existing lines of hESC 414 lines are available in 20 countries Characterization of these lines is limited- only 49% of lines are published in peer reviewed journals Guhr et al Stem cells 2006;24:2187-91 Derivation of hESC : 12/28/2009 Derivation of hESC Frozen embryos from IVF cycleExpanded blastocyst – ICMimmunosurgical isolation Quality poor-2nd quality embryos-cryoppreservation damages Simon et al Fertil Steril 2005;83:246-9 Maintenance of hESC : 12/28/2009 Maintenance of hESC Immortal cells in undifferentiated state Optimal growth conditions for future therapeutic applications Majority of hESC have been isolated and maintained in fetal calf serum and mouse embryonic fibroblasts as feeder cell layers (Xenoproteins and xenosupports) Problems : 12/28/2009 Problems Transmission of interspecies virus transfer Incorporation of foreign sugar molecule to hESC leading to immune response It may also lead to impairment of cell function & tissue development Varki Am J Phys Anthropol Suppl 2001 Research focus is on…. : 12/28/2009 Research focus is on…. Use of human components instead of animal sources to avoid zoonosis Fetal, adult muscle tissue, skin, Fallopian tube, endometrium, foreskin cells Successful undifferentiated growth of hESC using xenobiotic –free feeder system Richards ,Stem cells 2003;21:546-56 Research focus is on… : 12/28/2009 Research focus is on… Feeder free culture system from recombinant sources Ludwig Nature Biotech 2006;24:185-7 Differentiation : 12/28/2009 Differentiation Direct hESC to differentiate into specific cell lines - drug development- cell replacement therapeutics Specific germ cell layers can be directed by adding specific growth factors Scientific Stem Cell Challenges : 12/28/2009 Scientific Stem Cell Challenges Stem cells represents a very small fraction of cells in tissue. Isolate a small number of stem cells (finding a needle in a haystack). Expand the number of stem cells for research and clinical applications. Maintain genetic stability in culture and in recipient. Culture media has to be free of animal protein. Deliver cells to tissue of interest. Stem cells have to be functional. Avoid or restrict tissue rejection. Challenges to Stem Cell/Cloning Research : 12/28/2009 Challenges to Stem Cell/Cloning Research differentiation to the appropriate cell type(s) before using clinically. Recently, chromosome abnormalities in three human ESC lines. Challenges to Stem Cell/Cloning Research : 12/28/2009 Challenges to Stem Cell/Cloning Research Stem cell development or proliferation must be controlled once placed into patients. Possibility of rejection of stem cell transplants as foreign tissues is very high. Beware : 12/28/2009 Beware Private companies promising wonders with stem cells - mostly in countries with unregulated lawsIlic D, Regenerative med 2006;1:1-4 UKRAINE –capital of ESC ? but the references they quote do not have international authenticity in peer reviewed journals Slide 36: 12/28/2009 Slide 37: 12/28/2009